Biggest News Aggregation in the World
📰 Ned Mitchell News

Ned Mitchell News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ned Mitchell. Real-time updates on events, politics, business and more.

Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Derma

Exclusive Distributor Agreement with Symatese Broadens Evolus’ Dermal Filler Footprint Beyond the U.S. to Include the United Kingdom and EuropeEuropean Regulatory Approvals Anticipated in Second Half of 2024Company Continues to Expect to be Fully Funded to Profitability1NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus...
United Kingdom David Moatazedi Ned Mitchell Laurent Brones Eric Perouse Janet Kettels

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant in December of an aggregate of 28,328 restricted stock units (RSUs) of the company’s common stock to 7 newly hired non-executi...
Ned Mitchell Daewoong Pharmaceutical Co Ltd Arbor Advisory Group Evolus Inc Incentive Plan Nasdaq Listing Rule

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant in October of non-qualified stock options to purchase an aggregate of 63,703 shares of Evolus and an aggregate of 70,320 restr...
Ned Mitchell Company The November Arbor Advisory Group Daewoong Pharmaceutical Co Ltd Evolus Inc Incentive Plan

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U

Record Quarterly Net Revenue of $50 Million for Q3 2023, Up 48% from Q3 2022Raises Full-Year 2023 Net Revenue Guidance from $185 to $195 Million to $194 to $198 MillionOperating Use of Cash in Q3 of $0.9 Million, Demonstrating Continued Progress Towards Achieving Profitability1 with Existing Liquidity“Extra-Strength...
United States Newport Beach New South Wales Rui Avelar Allergan Medytox Ned Mitchell

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science